Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.

The global luxury sector enters the second half of 2026 confronting a compounding polycrisis of economic volatility, ...

Perhaps it’s no surprise that the man who made his name as the mayor of Manchester is in favour of more devolution.

AbbVie’s $10.9B Apogee deal strengthens immunology beyond Humira, adds Zumilokibart optionality, and may be undervalued. See ...

In a new study published in Nature Physics, researchers have demonstrated the Hong–Ou–Mandel (HOM) effect with up to 12 ...

The release of the CBSE Class 12 revaluation results on June 22 brought an extraordinary success story from Ranchi. Commerce ...

For Andy Burnham, it was a defining political moment. In 2009, the fresh-faced New Labour cabinet minister stood in a suit and wide tie at Anfield to pay his respects on behalf of the government at ...

Merck’s MRK stock climbed above its 50-day SMA from early June after trading below it for most of May. However, the stock has consistently been trading above its 200-day SMA since October 2025, which ...

Kemi Badenoch has mocked Labour after a party figure claimed Andy Burnham would be their “first woman prime minister”.

Nikesh Kooverjee has been contributing to the automotive sphere for 11 years. His previous roles include Digital Editor at CAR South Africa and associate editor at CarBuzz. He has always had a strong ...

Objective While guidelines advocate renin-angiotensin system inhibitors (RASi) for renoprotection in lupus nephritis (LN), ...